Is Farnesyltransferase Inhibitor Effective in Hamster Experimental Pancreatic Cancer Model as Neoadjuvant and Adjuvant Treatment? (original) (raw)
Statins Reduce the Risk of Pancreatic Cancer in Humans
Vikas Khurana
Pancreas, 2007
View PDFchevron_right
Cloning of the hamster p16 gene 5′ upstream region and its aberrant methylation patterns in pancreatic cancer
Kanya Honoki
Biochemical and Biophysical Research Communications, 2005
View PDFchevron_right
The Effect of Smoking, Alcohol and Narcotics on Results of CCK-Stimulated Pancreas Function Testing
Luis Alfonso Reyes Lara
Pancreas, 2004
View PDFchevron_right
Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas
Maryelba Schutte
Cancer research, 1997
View PDFchevron_right
Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4
Claudio Sorio
Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medicin, 2002
View PDFchevron_right
Infrequent alterations of thep16INK4A gene in liver cancer
Naoshi Nishida
International Journal of Cancer, 1996
View PDFchevron_right
Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse
Lynda Chin
2006
View PDFchevron_right
Tumor Suppressor p16INK4A: Determination of Solution Structure and Analyses of Its Interaction with Cyclin-Dependent Kinase 4
Thomas Selby
Molecular Cell, 1998
View PDFchevron_right
Genetic profile of 22 pancreatic carcinoma cell lines
Matthias Löhr, C. Sorio
Virchows Archiv, 2001
View PDFchevron_right
Aberrant Methylation of Preproenkephalin and p16 Genes in Pancreatic Intraepithelial Neoplasia and Pancreatic Ductal Adenocarcinoma
Robb Wilentz
The American Journal of Pathology, 2002
View PDFchevron_right
Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo
Gloria Su
Oncotarget, 2011
View PDFchevron_right
Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-Leiden)
Wilma Bergman
Clinical Cancer Research an Official Journal of the American Association For Cancer Research, 2003
View PDFchevron_right
Epidural Anesthesia Restores Pancreatic Microcirculation and Decreases the Severity of Acute Pancreatitis
Jean-louis Frossard
Pancreas, 2004
View PDFchevron_right
A rat model of pancreatic ductal adenocarcinoma: Targeting chemical carcinogens
Fiona Graeme-Cook
Surgery, 1997
View PDFchevron_right
TUMOR SUPPRESSING FUNCTIONS OF p16INK4a - A REVIEW
Elza Ibrahim
Journal of Dentistry Indonesia, 2003
View PDFchevron_right
Molecular biology of pancreatic cancer
Petra Minarikova
World Journal of Gastroenterology, 2011
View PDFchevron_right
Expression of p16Ink4a Compensates for p18Ink4c Loss in Cyclin-Dependent Kinase 4/6-Dependent Tumors and Tissues
Norman Sharpless
Cancer Research, 2007
View PDFchevron_right
Increased stability of P21 WAF1/CIP1 mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate
Chiara Costanzo
Biochimica Et Biophysica Acta-molecular Cell Research, 2006
View PDFchevron_right
Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic
Ana García García
International Journal of Molecular Sciences, 2021
View PDFchevron_right
Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene
Gloria Su
Cancer Research, 1998
View PDFchevron_right
BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) Mutations in Distinct Subsets of Pancreatic Cancer
Eric Calhoun
The American Journal of Pathology, 2003
View PDFchevron_right
The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4
Michael Kelley
Clinical cancer research : an official journal of the American Association for Cancer Research, 1999
View PDFchevron_right
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression
Robb Wilentz
Cancer research, 1998
View PDFchevron_right
Murine pancreatic tumor cell line TD2 bears the characteristic pattern of genetic changes with two independently amplified gene loci
Alexander Fingerle
Oncogene, 2003
View PDFchevron_right
Molecular analysis of the cyclin-dependent kinase inhibitor genesp15INK4b/MTS21,p16INK4/MTS1,p18 andpl9 in human cancer cell lines
Curtis Harris, Koichi Hagiwara
International Journal of Cancer, 1996
View PDFchevron_right
What We Have Learned About Pancreatic Cancer From Mouse Models
Carmen Guerra
Gastroenterology, 2012
View PDFchevron_right
Tumor suppressor p16 INK4A / Cdkn2a alterations in 7, 12-dimethylbenz(a)anthracene (DMBA)-induced hamster cheek pouch tumors
Thomas Knobloch
Molecular Carcinogenesis, 2008
View PDFchevron_right
Multiple Kinase Pathways Involved in the Different De Novo Sensitivity of Pancreatic Cancer Cell Lines to 17-AAG
Ti David
Journal of Surgical Research
View PDFchevron_right
Molecular Research in Pancreatic Cancer: Small Molecule Inhibitors, Their Mechanistic Pathways and Beyond
Nneoma James
Current Issues in Molecular Biology
View PDFchevron_right
Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective
Gregory Tsiotos
Cancer Treatment Reviews, 2000
View PDFchevron_right
Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
Peter Jones
Cancer research, 1995
View PDFchevron_right
Mutations and altered expression of p16INK4 in human cancer
Koichi Hagiwara
Proceedings of the National Academy of Sciences, 1994
View PDFchevron_right
Establishment and Characterization of 4 New Human Pancreatic Cancer Cell Lines
Daniela Campani
Pancreas, 2009
View PDFchevron_right